Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Jan 2020 09:11

RNS Number : 1377Z
Silence Therapeutics PLC
08 January 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

SILENCE THERAPEUTICS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Société Générale SA (SG SA)

City and country of registered office (if applicable)

Puteaux, France

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

06/01/2020

6. Date on which issuer notified (DD/MM/YYYY):

07/01/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.62%

0.00%

6.62%

78,370,265

Position of previous notification (if

applicable)

7.18%

0.00%

7.18%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B9GTXM62

Ordinary shares

5,191,202

0

6.62%

0%

GB00B9GTXM62

Borrowed Ordinary shares

0

0

0%

0%

SUBTOTAL 8. A

5,191,202

6.62%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

SUBTOTAL 8.B.2

0

0%

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London, United Kingdom

Date of completion

January 7th, 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUWRKRRKUARRR
Date   Source Headline
24th Apr 20094:35 pmRNSPrice Monitoring Extension
1st Apr 20097:00 amPRNUnaudited Preliminary Results
30th Mar 200912:15 pmPRNNotice of Results
27th Mar 20094:40 pmRNSSecond Price Monitoring Extn
27th Mar 20094:35 pmRNSPrice Monitoring Extension
19th Mar 20091:22 pmPRNHolding(s) in Company
16th Feb 20093:37 pmPRNHolding(s) in Company
21st Jan 20097:00 amPRNStatement re Patent Update
19th Jan 20091:00 pmPRNHolding(s) in Company
15th Jan 20093:00 pmPRNTotal Voting Rights
15th Jan 20099:45 amPRNHolding(s) in Company
13th Jan 20094:36 pmRNSPrice Monitoring Extension
12th Jan 20097:00 amPRNStatement re Change of operating address
9th Jan 200911:20 amPRNStatement re Patent Grant
8th Jan 20092:21 pmPRNResearch Update
8th Jan 200912:03 pmPRNIssue of Equity
5th Jan 20094:40 pmRNSSecond Price Monitoring Extn
5th Jan 20094:35 pmRNSPrice Monitoring Extension
2nd Jan 20094:35 pmRNSPrice Monitoring Extension
31st Dec 200812:40 pmRNSSecond Price Monitoring Extn
31st Dec 200812:36 pmRNSPrice Monitoring Extension
31st Dec 20087:00 amPRNTotal Voting Rights
18th Dec 20084:35 pmRNSPrice Monitoring Extension
12th Dec 20084:40 pmRNSSecond Price Monitoring Extn
12th Dec 20084:36 pmRNSPrice Monitoring Extension
11th Dec 20087:10 amPRNHolding(s) in Company
10th Dec 20087:00 amPRNStatement re Patent Decision
5th Dec 200812:05 pmPRNIssue of Equity
4th Dec 20087:00 amPRNResearch Update
1st Dec 20087:00 amPRNResearch Update
18th Nov 20087:00 amPRNStatement re Patent Issue
13th Nov 20081:00 pmPRNHolding(s) in Company
10th Nov 20084:44 pmRNSSecond Price Monitoring Extn
10th Nov 20084:37 pmRNSPrice Monitoring Extension
29th Oct 200811:00 amPRNHolding(s) in Company
27th Oct 20089:45 amPRNDirector/PDMR Shareholding
22nd Oct 200812:51 pmPRNDirector/PDMR Shareholding
22nd Oct 20087:00 amPRNDirector/PDMR Shareholding
17th Oct 20083:34 pmPRNAGM Statement
8th Oct 200810:15 amPRNHolding(s) in Company
26th Sep 20085:05 pmPRNDirector/PDMR Shareholding
26th Sep 200811:55 amPRNStatement re Intellectual Property
25th Sep 20087:00 amPRNHalf-yearly Report
24th Sep 200811:40 amPRNHolding(s) in Company
29th Aug 200812:15 pmPRNHolding(s) in Company
26th Aug 20085:11 pmPRNHolding(s) in Company
7th Aug 20088:57 amPRNHolding(s) in Company
5th Aug 20082:00 pmPRNHolding(s) in Company
31st Jul 20087:00 amPRNStatement re Notice of Patent Allowance
30th Jul 20084:25 pmPRNStatement re Notice of Patent Allowance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.